文献速递甲状腺疾病

隈医院低危甲状腺微小乳头状癌主动监测实施趋势:接受度逐渐增加且存在异质性

Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option.
PubMed 文献 · Thyroid · 2018-04-02

本研究纳入隈医院1993年10月至2016年6月共24年间细胞学诊断为低危甲状腺微小乳头状癌的4023例患者,分析主动监测使用频率随时间的变化趋势。结果显示主动监测总体使用频率为65%,从1993-1997年的30%逐渐升至2014-2016年的88%,但2003-2006年较1998-2002年略有下降;2007年前患者多由外科医生诊治且不同外科医生间主动监测使用频率差异显著,2007年后由内分泌科医生决定治疗策略的患者增多,内分泌科医生的主动监测使用频率高于外科医生。

要点

  • 隈医院24年间低危甲状腺微小乳头状癌主动监测总体使用频率为65%。
  • 主动监测使用频率从1993-1997年的30%逐渐升至2014-2016年的88%。
  • 2007年后内分泌科医生决定的主动监测使用频率高于外科医生。

核心结论

  • 在隈医院24年研究期间,低危甲状腺微小乳头状癌的主动监测接受度逐渐增加,但并非所有医生同等接受主动监测。
  • 作者预计其他医院也存在医生间对主动监测接受度的差异,但随着主动监测安全性和优于立即手术的证据增加,预计主动监测在日本及世界其他医院将更快获得接受。

研究设计与样本

  • 本研究为单中心历史队列分析,纳入隈医院1993年10月至2016年6月24年间细胞学诊断为低危甲状腺微小乳头状癌的4023例患者。
  • 将24年研究期按主动监测使用频率变化分为五段:1993-1997年、1998-2002年、2003-2006年、2007-2013年和2014-2016年,分析主动监测使用频率随时间的变化趋势。

主要发现

  • 本队列中主动监测使用频率为65%。
  • 主动监测使用频率从1993-1997年的30%逐渐升至2014-2016年的88%,期间从1998-2002年的51%略降至2003-2006年的42%。
  • 2007年前患者多由外科医生诊治,主动监测使用频率在不同外科医生间差异显著。
  • 2007年后由内分泌科医生决定治疗策略的患者数量增加,内分泌科医生对低危甲状腺微小乳头状癌的主动监测使用频率高于外科医生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Active surveillance (AS) of low-risk papillary thyroid microcarcinoma (PMC) was adopted as a management modality in both the Japanese guidelines in 2011 and the American Thyroid Association guidelines in 2015. AS was initiated at Kuma Hospital in 1993 but was not immediately accepted by all physicians. This study investigated the history of acceptance of AS at Kuma Hospital over time. The results should assist in the implementation of AS at other hospitals in Japan and other countries. METHODS: This study included 4023 patients who were cytologically diagnosed with low-risk PMC at Kuma Hospital during the 24-year period between October 1993 and June 2016. The trend in the frequency of AS use over time was analyzed, dividing the 24-year study period into five parts based on the change in frequency of AS use: 1993-1997, 1998-2002, 2003-2006, 2007-2013, and 2014-2016. RESULTS: The frequency of AS use in the present cohort was 65%. The frequency gradually increased from 30% in 1993-1997 to 88% in 2014-2016, with a slight decrease from 51% in 1998-2002 to 42% in 2003-2006. Until 2007, patients were mostly seen by surgeons, and the frequency of AS use varied remarkably among individual surgeons. Since 2007, the number of patients whose therapeutic strategies are determined by endocrinologists has increased, and the frequency of AS use for low-risk PMC by endocrinologists has been higher than that by surgeons. CONCLUSIONS: At Kuma Hospital, acceptance of AS for low-risk PMC gradually increased over the 24-year study period, but AS was not equally accepted by all physicians. Such variations in the acceptance of AS among individual physicians are also expected to exist in other hospitals. However, due to increasing evidence of the safety and superiority of AS over immediate surgery for this indolent disease, it is expected that AS will gain faster acceptance in other hospitals in Japan and around the world.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Ito Y, Miyauchi A, Kudo T, et al. Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option. Thyroid. 2018. PMID: 29608416. doi:10.1089/thy.2017.0448

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。